HealthLeaders Media November 16, 2018
John Commins

The Health and Human Services Secretary has launched a string of ambitious and aggressive initiatives, but he’s also careful not to get too far in front of President Donald Trump.

KEY TAKEAWAYS

Azar comments on social determinants are ‘piggybacking on an industry discussion.’

The HHS secretary is a pragmatist who knows he has to act on reducing drug costs.

Hospital consolidation and its effects on rising care costs may have to be addressed in 2019.

It’s been another interesting week of pronouncements from Health and Human Services Secretary Alex Azar.

In the past month, Azar has called for mandatory transparency in drug pricing, floated the idea of linking Medicare Part B drug prices to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Govt Agencies, Health System / Hospital, HHS, Mergers & Acquisitions / JV, Pharma, Pricing / Spending, Provider, Trends
HHS releases national suicide prevention strategy, plan
All Gas No Brakes - The FTC, DOJ, and HHS Unveil Online Reporting Portal as Latest Effort to Combat Unfair and Anticompetitive Health Care Practices
HHS Issues Final Rule Strengthening HIPAA Protections for Reproductive Healthcare
HHS finalizes reproductive health data protections
Hospitals could be asked to report emissions in 2026

Share This Article